Maravai LifeSciences Holdings, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Maravai LifeSciences Holdings, Inc. (MRVI) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$9.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$9.21M.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$2.64M.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$27.33M.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$19.50M.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$99.99M.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$114.78M.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$19.35M, a 107.15% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $270.46M, a 5.83% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.21M 10-Q · filed 2026-08-07 | -$11.86M 10-Q · filed 2026-08-07 | -$39.19M derived: sum of 3 quarters · filed 2026-08-07 | -$58.69M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | -$2.64M 10-Q · filed 2026-05-08 | -$29.98M derived: sum of 2 quarters · filed 2026-05-08 | -$49.48M derived: sum of 3 quarters · filed 2026-05-08 | -$79.72M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | -$27.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$46.84M derived: sum of 2 quarters · filed 2026-02-26 | -$77.08M derived: sum of 3 quarters · filed 2026-08-07 | -$99.99M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$19.50M 10-Q · filed 2025-11-07 | -$49.75M derived: sum of 2 quarters · filed 2026-08-07 | -$72.66M 10-Q · filed 2025-11-07 | -$92.82M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | -$30.25M 10-Q · filed 2026-08-07 | -$53.15M 10-Q · filed 2026-08-07 | -$73.32M derived: sum of 3 quarters · filed 2026-08-07 | -$148.70M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | -$22.91M 10-Q · filed 2026-05-08 | -$43.07M derived: sum of 2 quarters · filed 2026-05-08 | -$118.45M derived: sum of 3 quarters · filed 2026-05-08 | -$127.08M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$20.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$95.54M derived: sum of 2 quarters · filed 2026-02-26 | -$104.17M derived: sum of 3 quarters · filed 2026-02-26 | -$114.78M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$75.38M 10-Q · filed 2025-11-07 | -$76.92M 10-Q · filed 2024-11-12 | -$84.01M derived: sum of 2 quarters · filed 2025-11-07 | -$94.61M 10-Q · filed 2025-11-07 | -$94.43M 10-Q · filed 2024-11-12 | -$98.64M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$8.63M 10-Q · filed 2025-08-11 | -$6.91M 10-Q · filed 2024-08-08 | -$19.23M 10-Q · filed 2025-08-11 | -$17.51M 10-Q · filed 2024-08-08 | -$23.26M derived: sum of 3 quarters · filed 2026-02-26 | -$31.90M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$10.60M 10-Q · filed 2025-05-12 | -$14.63M derived: sum of 2 quarters · filed 2026-02-26 | -$23.27M derived: sum of 3 quarters · filed 2026-02-26 | -$28.67M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$12.66M derived: sum of 2 quarters · filed 2026-02-26 | -$18.07M derived: sum of 3 quarters · filed 2026-02-26 | -$19.35M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$8.64M 10-Q · filed 2024-11-12 | -$14.04M derived: sum of 2 quarters · filed 2024-11-12 | -$15.32M 10-Q · filed 2024-11-12 | $34.47M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | -$5.40M 10-Q · filed 2024-08-08 | -$6.68M 10-Q · filed 2024-08-08 | $43.11M derived: sum of 3 quarters · filed 2025-03-18 | $98.30M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | -$1.28M 10-Q · filed 2024-05-09 | $48.51M derived: sum of 2 quarters · filed 2025-03-18 | $103.70M derived: sum of 3 quarters · filed 2025-03-18 | $189.18M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $49.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $104.98M derived: sum of 2 quarters · filed 2025-03-18 | $190.46M derived: sum of 3 quarters · filed 2025-03-18 | $270.46M 10-K · filed 2025-03-18 | |||
| 2022-09-30 | $55.18M 10-Q · filed 2023-11-08 | $140.66M derived: sum of 2 quarters · filed 2023-11-08 | $220.66M 10-Q · filed 2023-11-08 | $291.94M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $85.48M 10-Q · filed 2023-08-08 | $165.48M 10-Q · filed 2023-08-08 | $236.76M derived: sum of 3 quarters · filed 2024-02-29 | $314.98M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $80.00M 10-Q · filed 2023-05-09 | $151.28M derived: sum of 2 quarters · filed 2024-02-29 | $229.49M derived: sum of 3 quarters · filed 2024-02-29 | $314.85M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $71.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $149.50M derived: sum of 2 quarters · filed 2024-02-29 | $234.85M derived: sum of 3 quarters · filed 2024-02-29 | $287.21M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $78.22M 10-Q · filed 2022-11-04 | $78.54M 10-Q · filed 2021-11-15 | $163.57M derived: sum of 2 quarters · filed 2022-11-04 | $215.93M 10-Q · filed 2022-11-04 | $216.41M 10-Q · filed 2021-11-15 | $205.19M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $85.35M 10-Q · filed 2022-08-05 | $85.27M 10-Q · filed 2021-08-11 | $137.72M 10-Q · filed 2022-08-05 | $137.87M 10-Q · filed 2021-08-11 | $126.98M derived: sum of 3 quarters · filed 2023-02-28 | $127.05M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $52.36M 10-Q · filed 2022-05-06 | $52.60M 10-Q · filed 2021-05-12 | $41.63M derived: sum of 2 quarters · filed 2023-02-28 | $41.70M derived: sum of 3 quarters · filed 2023-02-28 | $41.72M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$10.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$10.66M derived: sum of 2 quarters · filed 2023-02-28 | -$10.65M derived: sum of 3 quarters · filed 2023-02-28 | -$10.16M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $73.00K 10-Q · filed 2021-11-15 | $92.00K derived: sum of 2 quarters · filed 2021-11-15 | $582.00K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $19.00K 10-Q · filed 2021-08-11 | $509.00K 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $490.00K 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | -$731.00K 10-K · filed 2022-03-01 |